Title of article :
Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)
Author/Authors :
Labinaz، نويسنده , , Marino and Madan، نويسنده , , Mina and O’Shea، نويسنده , , J.Conor and Kilaru، نويسنده , , Rakhi and Chin، نويسنده , , Wai and Pieper، نويسنده , , Karen Ashlee McGuire، نويسنده , , Darren K and Saucedo، نويسنده , , Jorge F and Talley، نويسنده , , David and Lui، نويسنده , , Henry and Kitt، نويسنده , , Michael J. and Califf، نويسنده , , Robert M and Tcheng، نويسنده , , James E، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2002
Pages :
6
From page :
585
To page :
590
Abstract :
For patients undergoing nonurgent coronary stent implantation, blockade of the glycoprotein IIb/IIIa receptor with eptifibatide reduces the incidence of ischemic complications. We evaluated the interaction of eptifibatide with diabetes in patients who und
Journal title :
American Journal of Cardiology
Serial Year :
2002
Journal title :
American Journal of Cardiology
Record number :
1894566
Link To Document :
بازگشت